This is a single dose vaccine against human papillomavirus.
World Health Organization (WHO) confirmed inclusion Tsekolin as a fourth single-dose vaccine against human papillomavirus (HPV). This decision is based on new data that meets the criteria set out in the 2022 WHO guidelines for alternative off-label uses of the drug. HPV vaccinations in calendars.
“This important advance will improve the sustainable supply of HPV vaccines, which will allow us to reach more girls and prevent cervical cancer“,” noted the WHO. Tedros Adhanom Ghebreyesus, the organization’s director general, emphasized that “unlike many other types of cancer, we have the opportunity to eliminate cervical cancer and end the painful inequalities it breeds. The addition of another single-dose vaccination option brings us one step closer to classifying this disease as
HPV is responsible for more than 95% of the 660,000 annual cases of cervical cancer worldwide. A woman dies every two minutes from this preventable disease. 90% of these deaths They occur in low- and middle-income countries.
The rollout of the HPV vaccine has faced obstacles since 2018, mainly due to global supply shortage. The manufacturer’s production difficulties in 2024 have worsened the situation, affecting the vaccination of millions of girls.
The goal of WHO’s global strategy is to vaccinate 90% of girls under the age of 15, explained Kate O’Brien, director of the WHO Department of Immunization. “As supply issues still exist, the addition of single-dose vaccines provides greater opportunity to vaccinate more people.”
Single dose recommendation Tsekolin It is already included in the second edition of the WHO technical document on HPV vaccine selection. If there is evidence to support a modified use and the public health benefit is clear, WHO may recommend a use not originally included in the product label, pending an update.
The latest data, published July 15, 2024, indicates that one-dose HPV vaccine coverage for girls aged 9 to 14 years increased from 20% in 2022 to 27% in 2023. By September 2024 57 countries have already introduced a single vaccine. -a dose regimen that allowed six million children to be vaccinated.
Earlier this year, more than $600 million was announced to help eradicate cervical cancer. Among donors Bill and Melinda Gates Foundationwith 180 million dollars; UNICEF – 10 million; and the World Bank – 400 million. These funds, along with continued support from Gavi, will accelerate HPV vaccination and increase coverage until 2030.
Can men get HPV?
Definitely yes. Men become infected with HPV in a relationship with a woman or man who is also infected. As for uterine cancer, they become carriers of the virus to other people. This means that if we avoided infecting men, we would significantly reduce transmission in women (and in men in relationships with other men), and therefore we would also reduce all genital tract diseases caused by that same infection. infections, says the Sanabria clinic. Men who have sexual relations with other men are at particular risk of contracting infections and tumors secondary to HPV, which is why some autonomous communities have special funded vaccination programs, as is the case in Andalusia or Madrid.